(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHARMAKONNECT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PHARMAKONNECT

ST13

US500000097618206

Class

35

Filing

97618206

Registration

7217389

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

14

Latest update

11/14/2023

Trademark type

Combined

Nice classes

35

Filing date

10/04/2022

Registration date

11/14/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/14/2023

Last transaction

11/14/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

12/16/2021

First use in commerce

12/16/2021

Drawing code

3

Owner type

16

Owner location

Mt. Dora, FL, US

Examiner

HARDY LUDLOW, TARAH KIM

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of dots of varying sizes and colors going from orange to pink, some of which are connected and which form the shape of a circle situated to the left of the word "PHARMAKONNECT" in black.

Holders and representatives

Holders

PharmaKonnect LLC

Representatives

KELLY G. SWARTZ WIDERMAN MALEK, PL

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business data analysis services in the field of pharmacy operations; Business data analysis services in the field of pharmacy patient experience

Publications

History of USPTO decisions and trademark events.

14 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/14/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

11/14/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/29/2023

PUBO

PUBLISHED FOR OPPOSITION

08/29/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/09/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/26/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

07/26/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/26/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

07/26/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/26/2023

DOCK

ASSIGNED TO EXAMINER

07/19/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/21/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/20/2022

NWAP

NEW APPLICATION ENTERED

10/07/2022

Continuous trademark protection

Get notified about every new filing that threatens PHARMAKONNECT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.